CRMD · NASDAQ
CorMedix (CRMD) Stock Price & Fundamentals
CorMedix (CRMD) closed at $475.38 on Oct 9, 2026, down 1.21% from the previous close of $481.20.
Share price, past year
1Y +2.49%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $475.38 |
| Sep 30, 2026 | $473.63 |
| Aug 31, 2026 | $470.46 |
| Jul 31, 2026 | $467.92 |
| Jun 30, 2026 | $459.35 |
| May 29, 2026 | $481.02 |
| Apr 30, 2026 | $483.36 |
| Mar 31, 2026 | $482.46 |
| Feb 27, 2026 | $490.17 |
| Jan 30, 2026 | $481.42 |
| Dec 31, 2025 | $483.23 |
| Nov 28, 2025 | $470.89 |
| Oct 31, 2025 | $479.09 |
Key statistics
- Market cap
- $36.92B
- P/E (TTM)
- 218.1
- EPS (TTM)
- $2.18
- Revenue (TTM)
- $462.25M
- Net income (TTM)
- $187.17M
- Shares outstanding
- 77.7M
- Dividend yield
- —
- 52-week range
- $458.04 – $506.65
CorMedix's market cap is $36.92B, based on a share price of $475.38 and 77.7M shares outstanding as of Jun 30, 2026.
Financials
CorMedix reported revenue of $311.71M for fiscal 2025, up 617.03% from fiscal 2024.
CorMedix earned net income of $163.06M in fiscal 2025, a net margin of 52.3%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $311.71M | +617.0% | $163.06M | 52.3% | $2.04 | $172.79M |
| FY2024ended Dec 31, 2024 | $43.47M | +66,362.8% | −$17.93M | −41.2% | −$0.30 | −$50.73M |
| FY2022ended Dec 31, 2022 | $65.41K | −65.7% | −$29.70M | −45,409.9% | −$0.74 | −$24.58M |
| FY2021ended Dec 31, 2021 | $190.94K | −20.2% | −$28.21M | −14,774.7% | −$0.75 | −$22.58M |
| FY2020ended Dec 31, 2020 | $239.23K | −15.6% | −$22.03M | −9,207.7% | −$0.77 | −$22.08M |
| FY2019ended Dec 31, 2019 | $283.27K | −34.1% | −$16.43M | −5,801.3% | −$1.80 | −$15.09M |
| FY2018ended Dec 31, 2018 | $429.80K | +30.5% | −$26.83M | −6,242.4% | −$1.51 | −$23.75M |
| FY2017ended Dec 31, 2017 | $329.33K | +47.0% | −$33.01M | −10,023.5% | −$0.60 | −$28.74M |
| FY2016ended Dec 31, 2016 | $224.11K | +6.7% | −$24.64M | −10,996.5% | −$0.65 | −$22.32M |
| FY2015ended Dec 31, 2015 | $210.13K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $101.93M | $25.99M | $0.29 |
| Q1 FY2026ended Mar 31, 2026 | $127.43M | $38.60M | $0.43 |
| Q4 FY2025ended Dec 31, 2025 | $128.62M | $14.02M | $0.20 |
| Q3 FY2025ended Sep 30, 2025 | $104.28M | $108.56M | $1.26 |
| Q2 FY2025ended Jun 30, 2025 | $39.74M | $19.83M | $0.28 |
| Q1 FY2025ended Mar 31, 2025 | $39.08M | $20.64M | $0.30 |
| Q3 FY2024ended Sep 30, 2024 | $11.46M | −$2.78M | −$0.05 |
| Q2 FY2024ended Jun 30, 2024 | $806.12K | — | — |
Company profile
- Name
- CorMedix Inc.
- Ticker
- CRMD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 389 Interpace Pkwy, Suite 450, Parsippany, NJ 07054
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001410098
Recent SEC filings
- Aug 13, 2026
- Aug 13, 2026
- Aug 7, 2026
- Jul 2, 2026
- Jul 1, 2026
- Jun 24, 2026
- Jun 8, 2026
- May 14, 2026
Frequently asked questions
What is CorMedix's stock price?
CorMedix (CRMD) closed at $475.38 on Oct 9, 2026, down 1.21% from the previous close of $481.20.
What is CorMedix's market cap?
CorMedix's market cap is $36.92B, based on a share price of $475.38 and 77.7M shares outstanding as of Jun 30, 2026.
How much revenue does CorMedix make?
CorMedix reported revenue of $311.71M for fiscal 2025, up 617.03% from fiscal 2024.
What is CRMD's P/E ratio?
CorMedix's price-to-earnings ratio is 218.1, based on trailing twelve-month diluted EPS of $2.18.
Does CorMedix pay a dividend?
CorMedix's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from CorMedix Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures